Adagio Therapeutics (NASDAQ:ADGI) Shares Gap Up to $53.90

Adagio Therapeutics Inc (NASDAQ:ADGI)’s share price gapped up before the market opened on Monday . The stock had previously closed at $53.90, but opened at $56.00. Adagio Therapeutics shares last traded at $56.96, with a volume of 6,071 shares traded.

Several equities research analysts recently issued reports on ADGI shares. Jefferies Financial Group started coverage on Adagio Therapeutics in a report on Tuesday, August 31st. They set a “buy” rating and a $60.00 price target for the company. Morgan Stanley started coverage on Adagio Therapeutics in a report on Tuesday, August 31st. They set an “equal weight” rating and a $33.00 price target for the company. Guggenheim assumed coverage on Adagio Therapeutics in a report on Tuesday, August 31st. They set a “buy” rating and a $40.00 price target for the company. Finally, Stifel Nicolaus assumed coverage on Adagio Therapeutics in a research note on Tuesday, August 31st. They issued a “buy” rating and a $57.00 price objective for the company.

Adagio Therapeutics Company Profile (NASDAQ:ADGI)

Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. Adagio Therapeutics Inc is based in WALTHAM, Mass.

Read More: What is the price-sales ratio?

Receive News & Ratings for Adagio Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.